Systematic Review

Accepted on 24 Dec 2024

Efficacy and safety of anticoagulants on venous thromboembolism: A systematic review and network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Weijie Fu
Maolin Zhao
Sheng Ding
Mei Xin
Ke Yang
Li Jiang
Fan Wu
Xiaochen Wu
Jian Wang
Jie Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519869

Review

Published on 24 Dec 2024

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Junhui Qian
Jinlong Wan
Qin Yao
Yin Chen
Tao Ling
Yuejuan Zhang
Zhihua Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457226

124 views

Original Research

Accepted on 23 Dec 2024

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review and network metaanalysis

in Drugs Outcomes Research and Policies

Yan Chen
Jiaojiao Zhao
Yifei Wang
Long Ge
Joey S.W. Kwong
Junjie Lan
Rui Zhang
Huaye Zhao
Linfang Hu
Jiaxue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530999

Original Research

Accepted on 23 Dec 2024

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

in Drugs Outcomes Research and Policies

Haolong Han
Hang Xu
Jifan Zhang
Weihui Zhang
Yi Yang
Xia Wang
Li Wang
Dongjin Wang
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528390

Original Research

Published on 23 Dec 2024

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

in Drugs Outcomes Research and Policies

Przemyslaw Kardas
Bryan Bennett
Bijan Borah
Michel Burnier
Christopher Daly
Mickael Hiligsmann
Enrica Menditto
Andrew M. Peterson
Julia F. Slejko
Krisztina Tóth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444012

2,372 views

Original Research

Published on 20 Dec 2024

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

in Drugs Outcomes Research and Policies

Zuojuan Xiang
Ling Ma
Zhengxiong Li
Yingzhou Fu
Yong Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488645

199 views

Original Research

Accepted on 19 Dec 2024

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system

in Drugs Outcomes Research and Policies

Wenwang Lang
Yulong He
Changchun Hou
Hua Li
Qinling Jiang
Liuyong Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402423

Original Research

Accepted on 19 Dec 2024

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: Insights from semi-structured interviews

in Drugs Outcomes Research and Policies

Thomas Desmet
Sissel Michelsen
Elena Van Den Brande
Walter Van Dyck
Steven Simoens
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397531

Original Research

Accepted on 19 Dec 2024

Analysis of Drug Pricing Drivers under South Korea's Pharmaco-Economic Evaluation Exemption Policy (2015-2022)

in Drugs Outcomes Research and Policies

Jong Hyuk Lee
Seunga-Rae Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519491

Systematic Review

Published on 19 Dec 2024

Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review

in Drugs Outcomes Research and Policies

Ruochen Qu
Yan Liu
Yan Zhao
Ziyi Wang
Shizhao Yuan
Shuai Liu
Jing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450120

194 views

Systematic Review

Published on 18 Dec 2024

Literature review analysis of aortitis induced by granulocyte-colony stimulating factor

in Drugs Outcomes Research and Policies

Ting Zhao
Huanhuan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487501

151 views

Original Research

Published on 18 Dec 2024

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

in Drugs Outcomes Research and Policies

Martin Wawruch
Miriam Petrova
Denisa Celovska
Sofa D. Alfian
Tomas Tesar
Jan Murin
Michal Trnka
Tomas Paduch
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464689

235 views

Original Research

Accepted on 17 Dec 2024

Appropriateness and Inappropriate Medication Predictors of Stress Ulcer Prophylaxis in the Intensive Care Unit

in Drugs Outcomes Research and Policies

Pan Zhang
Siyang Wang
Tingting Zhi
Naobei Ye
Haonan Sun
Xingyu Qin
Shuhan Xu
Ruiqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401335

Original Research

Accepted on 17 Dec 2024

Analysis of Factors Influencing the Awareness of Inpatients Regarding Hospital Clinical Pharmacy Services and Willingness to Pay: A Multicenter Survey in Hebei Province, China

in Drugs Outcomes Research and Policies

Ruixia Yang
Xin Wang
Huizhen Wu
Qian Sun
Sijie Zhang
Qian Dong
Mengjiao Li
Xiaoli Xu
Jing Bai
Ping Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520058

Original Research

Accepted on 17 Dec 2024

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in South Africa

in Drugs Outcomes Research and Policies

Rochelle Woudberg
Edina Sinanovic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511603

Perspective

Published on 17 Dec 2024

Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem

in Drugs Outcomes Research and Policies

Jonathan Hare
Morten Nielsen
Agnes Kiragga
Daniel Ochiel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499079

369 views

Navigation group

Articles

Efficacy and safety of anticoagulants on venous thromboembolism: A systematic review and network meta-analysis of randomized controlled trials

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review and network metaanalysis

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: Insights from semi-structured interviews

Analysis of Drug Pricing Drivers under South Korea's Pharmaco-Economic Evaluation Exemption Policy (2015-2022)

Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review

Literature review analysis of aortitis induced by granulocyte-colony stimulating factor

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

Appropriateness and Inappropriate Medication Predictors of Stress Ulcer Prophylaxis in the Intensive Care Unit

Analysis of Factors Influencing the Awareness of Inpatients Regarding Hospital Clinical Pharmacy Services and Willingness to Pay: A Multicenter Survey in Hebei Province, China

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in South Africa

Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem